Patient safety in medical research is a critical concern that safeguards the welfare of individuals participating in clinical trials and studies.As research institutions like Harvard face funding cuts, the infrastructure that supports oversight, such as IRBs (Institutional Review Boards), may be compromised, raising alarms over potential public health implications.